Rheumatoid Forefoot Reconstruction Following Minimally Invasive Surgery and Hoffmann-Clayton Procedure with Administration of Plasma Rich in Growth Factors – A 3-Year Follow-Up: A Retrospective Study

dc.creatorShahul Hameed, Abdul Basith
dc.creatorMakinyan, Levon Gagikovich
dc.creatorShindiev, Kurban Ahmedovich
dc.creatorAliev, Rasul
dc.creatorSergeevich Apresyan, Vladislav
dc.creatorZaalan Wessam, Abo
dc.date2022-10-01
dc.date.accessioned2022-10-28T12:08:05Z
dc.date.available2022-10-28T12:08:05Z
dc.identifierhttp://saber.ucv.ve/ojs/index.php/rev_gmc/article/view/24524
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/4956028
dc.descriptionFrom 80 % to 90 % of foot deformities in adults are due to rheumatoid arthritis. Despite various surgical approaches, early functional and cosmetic results have been the greatest concern among patients. Thus, optimal surgical choice in rheumatoid forefoot correction is of vital importance for better subjective and clinical results. Thus, optimal surgical choice in rheumatoid forefoot correction is of vital importance for better subjective and clinical results. Our work evaluates the results of minimally invasive surgery (MIS) and resection arthroplasty per Hoffmann-Clayton along with the administration of Plasma Rich in Growth Factors (PRGF) in rheumatoid-affected forefoot patients.es-ES
dc.formatapplication/pdf
dc.languagespa
dc.publisherAcademia Nacional de Medicina venezolana.es-ES
dc.relationhttp://saber.ucv.ve/ojs/index.php/rev_gmc/article/view/24524/144814490750
dc.rightsDerechos de autor 2022 Gaceta Médica de Caracases-ES
dc.rightshttps://creativecommons.org/licenses/by-nc/4.0es-ES
dc.sourceGaceta Médica de Caracas; Vol. 130 Núm. 3 (2022)es-ES
dc.source2739-0012
dc.source0367-4762
dc.subjectRheumatoid arthritises-ES
dc.subjecthuman forefootes-ES
dc.subjectminimally invasive surgical procedureses-ES
dc.subjectplatelet-rich plasmaes-ES
dc.titleRheumatoid Forefoot Reconstruction Following Minimally Invasive Surgery and Hoffmann-Clayton Procedure with Administration of Plasma Rich in Growth Factors – A 3-Year Follow-Up: A Retrospective Studyes-ES
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion


Este ítem pertenece a la siguiente institución